Three fields are investigated by hospinnomics :
Patient and population preferences (ME1)
In the health care sector, decision-makers are increasingly facing the question of whose preferences should prevail: those of patients or those of the population? While clinicians are most likely to only give weight to individual patients’ preferences, economists bring collective preferences to the fore?
Hospinnomics has 2 objectives: to develop research that contributes to highlighting the methodological challenges introduced by using patients’ assessment of benefits in economic evaluation; to use original data and methods (in particular behavioral economics) to better understand patients’ preferences and attitudes.
- “Life style changes after health shocks” (ME11)
- “Screening for breast cancer” (ME12)
New quantitative approaches in health care (ME2)
Randomization is increasingly used in economics to evaluate interventions, under J-PAL’s (Poverty Action Lab) strong support. Few studies have used randomization for the economic (as opposed to clinical) evaluation of interventions in health care.
2 objectives are pursued: to support the use of randomization to evaluate interventions in health care along with adapting the methods and experimental designs to the specifics of economic evaluation in the health care field; to develop new data merging approaches.
- “Voisin-malin” (ME21)
- “Case management for professional injuries” (ME22)
- “Interactive network for chronic renal failure patients” (ME23)
- “Data linkage” (ME24)
Benefit measurement (ME3)
An important set of methodological questions in the field of the health care interventions assessments is the comparison of the psychometric properties of global versus local measures of quality of life.
Hospinnomics objective is to support the adoption of a full Health Technology Assessment (hereafter HTA) approach in economic evaluation, and to foster the generation of multidisciplinary evidence on these societal issues.
- “Ambulatory surgery” (ME31)
- “European Social Sciences Platform for paediatric oncology” (ME32)